Loading...
XSHG
600479
Market cap622mUSD
Dec 05, Last price  
10.75CNY
1D
-0.46%
1Q
-1.56%
Jan 2017
-18.19%
IPO
131.18%
Name

ZhuZhou QianJin Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHG:600479 chart
P/E
19.07
P/S
1.21
EPS
0.56
Div Yield, %
3.26%
Shrs. gr., 5y
-0.23%
Rev. gr., 5y
0.59%
Revenues
3.63b
-4.44%
665,825,902602,686,103679,777,224801,429,486904,270,114979,443,7661,256,527,2711,583,422,7331,972,855,0852,194,240,4702,446,684,0742,864,885,5123,182,743,7923,328,553,9633,525,238,1223,626,966,8083,663,844,6134,026,278,5933,798,485,3293,629,804,492
Net income
231m
-27.98%
59,863,87871,778,673173,619,322129,892,010130,913,57986,382,77982,821,345120,164,483123,767,862105,092,91092,959,634149,428,673207,758,270255,355,306294,313,213297,071,596302,063,356302,508,846320,405,834230,756,619
CFO
399m
-12.15%
76,501,036120,122,93979,263,36137,204,11773,541,73039,129,91622,578,202197,816,674137,632,243183,342,68867,484,546140,879,318283,466,753383,466,469155,493,890542,373,092485,573,058733,472,924453,932,674398,766,454
Dividend
Jun 27, 20240.35 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ZhuZhou QianJin Pharmaceutical Co.,Ltd produces and sells pharmaceutical products in China. The company provides gynecology, pediatrics, beauty, antimicrobial, circulatory, endocrine, specialty, digestive, nervous, and cardiovascular products, as well as traditional Chinese medicines It offers its products in various forms, including tablets, capsules, granules, pills, decoctions, powders, and solution. The company also provides ginger tea; feminine hygiene products; and wine. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1993 and is headquartered in Zhuzhou, China.
IPO date
Mar 12, 2004
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT